Publications by authors named "O Lenz"

Claim this Profile
V
Viral sequence analysis of chronic hepatitis B patients treated with the siRNA JNJ-73763989 in phase II clinical trials.
Thierry Verbinnen, Erkki Lathouwers, John Jezorwski, Michael Biermer, Ilse Augustyns, Oliver Lenz

JHEP Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NRVS Spectroscopy Resolves Distinct Bridging Hydride Intermediates in [NiFe]-Hydrogenase.
Giorgio Caserta, Konstantin Laun, Jean-Pierre Oudsen, Ilya Sergueev, Ingo Zebger, Oliver Lenz

J Am Chem Soc· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peginterferon alpha-2a add-on to siRNA JNJ-73763989 in untreated patients with HBeAg-positive chronic hepatitis B virus (HBV) infection: the phase 2 REEF-IT study.
Patrick T F Kennedy, Scott Fung, Maria Buti, Gurdal Yilmaz, Wan-Long Chuang, Oliver Lenz

Gut· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daily Mosnodenvir as Dengue Prophylaxis in a Controlled Human Infection Model.
Anna P Durbin, Liesbeth Van Wesenbeeck, Kristen K Pierce, Guillermo Herrera-Taracena, Laura Ebone, Oliver Lenz

N Engl J Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peginterferon-alpha-2a add-on to treatment with siRNA JNJ-73763989 in virologically suppressed chronic hepatitis B: The phase II PENGUIN study.
Edward Gane, Ewa Janczewska, Tetsuo Takehara, Wan-Long Chuang, Cheng-Yuan Peng, Oliver Lenz

JHEP Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis